$LNBY
Landbay Inc

2024 Q2 Form 10-K Financial Statement

#000149315224025788 Filed on July 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2024
Revenue $5.260K $9.539K
YoY Change -47.55%
Cost Of Revenue $3.770K $7.494K
YoY Change -6.58%
Gross Profit $1.490K $2.045K
YoY Change -79.88%
Gross Profit Margin 28.33% 21.44%
Selling, General & Admin $10.28K $43.16K
YoY Change -9.86%
% of Gross Profit 689.93% 2110.51%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $48.85K $10.28K $43.16K
YoY Change 190.78% -9.84%
Operating Profit -$48.85K -$8.790K -$41.12K
YoY Change 190.78% 9.04%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $23.00 $10.00 $27.98K
YoY Change 15.0% 64974.42%
Pretax Income $19.21K -$13.14K
YoY Change -65.12%
Income Tax $58.00
% Of Pretax Income
Net Earnings -$48.83K $19.21K -$13.14K
YoY Change 190.99% -65.12%
Net Earnings / Revenue 365.21% -137.72%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 30.00M shares 30.00M shares 30.00M shares
Diluted Shares Outstanding 30.00M shares 30.00M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $8.760K $8.760K
YoY Change 8.01%
Cash & Equivalents $8.761K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $8.761K $8.760K
YoY Change -43.84% -43.85%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $8.761K $8.760K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $8.761K $8.760K
YoY Change -43.84% -43.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $1.970K $1.970K
YoY Change 392.5%
Deferred Revenue
YoY Change
Short-Term Debt $43.83K $104.2K $104.2K
YoY Change 4.76%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $43.83K $106.2K $106.2K
YoY Change -60.66% 6.31% 6.31%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $43.83K $106.2K $106.2K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $43.83K $106.2K $106.2K
YoY Change -60.66% 6.31% 6.31%
SHAREHOLDERS EQUITY
Retained Earnings -$501.9K -$453.1K
YoY Change 9.89% 2.99%
Common Stock $30.00K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$43.83K -$97.39K -$97.39K
YoY Change
Total Liabilities & Shareholders Equity $8.761K $8.760K
YoY Change -43.84% -43.85%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2024
OPERATING ACTIVITIES
Net Income -$48.83K $19.21K -$13.14K
YoY Change 190.99% -65.12%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$50.79K -$4.650K -$32.08K
YoY Change 320.55% -11.86%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $42.03K 10.39K $32.73K
YoY Change 513.8% 78.31%
NET CHANGE
Cash From Operating Activities -$50.79K -4.650K -$32.08K
Cash From Investing Activities
Cash From Financing Activities $42.03K 10.39K $32.73K
Net Change In Cash -$8.761K 5.740K $656.00
YoY Change 67.51% -103.64%
FREE CASH FLOW
Cash From Operating Activities -$50.79K -$4.650K -$32.08K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001672572
CY2024Q1 us-gaap Inventory Net
InventoryNet
usd
CY2023 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
usd
CY2023 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
usd
CY2024 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2024 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023 LNBY Disposal For Fixed Assets Offset By Related Party Loan
DisposalForFixedAssetsOffsetByRelatedPartyLoan
usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Document Transition Report
DocumentTransitionReport
false
CY2024 dei Entity File Number
EntityFileNumber
000-56182
CY2024 dei Entity Registrant Name
EntityRegistrantName
LANDBAY INC
CY2024 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
CY2024 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-1260549
CY2024 dei Entity Address Address Line1
EntityAddressAddressLine1
Room 3501
CY2024 dei Entity Address Address Line2
EntityAddressAddressLine2
EFC Building, Yuhang District
CY2024 dei Entity Address City Or Town
EntityAddressCityOrTown
Hangzhou City
CY2024 dei Entity Address Country
EntityAddressCountry
CN
CY2024 dei City Area Code
CityAreaCode
+86
CY2024 dei Local Phone Number
LocalPhoneNumber
18621851468
CY2024 dei Security12g Title
Security12gTitle
Class A Common Stock
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
true
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Public Float
EntityPublicFloat
246720 usd
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
30000000 shares
CY2024 dei Auditor Firm
AuditorFirmId
2485
CY2024 dei Auditor Name
AuditorName
Simon & Edward, LLP
CY2024 dei Auditor Location
AuditorLocation
Rowland Heights, CA
CY2024Q1 us-gaap Cash
Cash
8761 usd
CY2023Q1 us-gaap Cash
Cash
8105 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
7494 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
8761 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
15599 usd
CY2024Q1 us-gaap Assets
Assets
8761 usd
CY2023Q1 us-gaap Assets
Assets
15599 usd
CY2024Q1 us-gaap Loans Payable Current
LoansPayableCurrent
104187 usd
CY2023Q1 us-gaap Loans Payable Current
LoansPayableCurrent
99456 usd
CY2024Q1 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
1966 usd
CY2023Q1 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
398 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
106153 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
99854 usd
CY2024Q1 us-gaap Liabilities
Liabilities
106153 usd
CY2023Q1 us-gaap Liabilities
Liabilities
99854 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30000000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30000000 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
30000 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
30000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
325659 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
325659 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-453051 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-439914 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-97392 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-84255 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8761 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15599 usd
CY2024 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9539 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18188 usd
CY2024 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7494 usd
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8022 usd
CY2024 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
43164 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
47876 usd
CY2024 us-gaap Operating Expenses
OperatingExpenses
43164 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
47876 usd
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
-41119 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-37710 usd
CY2024 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
28000 usd
CY2024 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-18 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
43 usd
CY2024 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
27982 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
43 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-13137 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-37667 usd
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30000000 shares
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30000000 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30000000 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30000000 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-84255 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-13137 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-97392 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-46588 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-84255 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-13137 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-37667 usd
CY2024 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
28000 usd
CY2024 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-7494 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7494 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9115 usd
CY2024 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
1568 usd
CY2023 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-345 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-32075 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-36391 usd
CY2024 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
32731 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
18356 usd
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
32731 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18356 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
656 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-18035 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8105 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26140 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8761 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8105 usd
CY2024 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
58 usd
CY2024 LNBY Disposal For Fixed Assets Offset By Related Party Loan
DisposalForFixedAssetsOffsetByRelatedPartyLoan
28000 usd
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84D_eus-gaap--UseOfEstimates_z2FC0gIq8UEl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zqjh1t4ugi81">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts and timing of revenues and expenses, the reported amounts and classification of assets and liabilities, and the disclosure of contingent assets and liabilities. Significant areas requiring the use of estimates are assessing the inventory write-down, impairment of long-lived assets and recoverability of deferred tax assets. These estimates and assumptions are based on the Company’s historical results as well as management’s future expectations. The Company’s actual results may vary from those estimates and assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
7494 usd
CY2024 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.065 pure
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
58 usd
CY2024 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
429359 usd
CY2023 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
323695 usd
CY2024Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
109057 usd
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
86568 usd

Files In Submission

Name View Source Status
0001493152-24-025788-index-headers.html Edgar Link pending
0001493152-24-025788-index.html Edgar Link pending
0001493152-24-025788.txt Edgar Link pending
0001493152-24-025788-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
image_001.jpg Edgar Link pending
lnby-20240331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lnby-20240331_cal.xml Edgar Link unprocessable
lnby-20240331_lab.xml Edgar Link unprocessable
lnby-20240331_def.xml Edgar Link unprocessable
lnby-20240331_pre.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending